Volatile Organic Compounds (VOCs) Found in Urine and Stool

Volatile Biomarkers

Volumn , Issue , 2013, Pages 405-462

  de Lacy Costello, Ben ^a   Ratcliffe, Norman M ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893418935     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-44-462613-4.00022-2     Document Type: Chapter

References (99)

1. Mills G.A., Walker V. Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations. J Chromatogr B Biomed Sci Appl 2001, 753:259-268.
2. Smith S., Burden H., Persad R., Whittington K., de Lacy Costello B., Ratcliffe N.M., et al. A comparative study of the analysis of human urine headspace using gas chromatography-mass spectrometry. J Breath Res 2008, 2:037022.
3. Wahl H.G., Hong Q., Hildenbrand S., Risler T., Luft D., Liebich H. 4-Heptanone is a metabolite of the plasticizer di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients. Nephrol Dial Transplant 2004, 19:2576-2583.
4. Garner C.E., Smith S., de Lacy Costello B., White P., Spencer R., Probert C.S., et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. Faseb J 2007, 21:1675-1688.
5. Penders J., Fiers T., Giri M., Wuyts B., Ysewyn L., Delanghe J.R. Quantitative measurement of ketone bodies in urine using reflectometry. Clin Chem Lab Med 2005, 43:724-729.
6. Bone E., Tamm A., Hill M. The production of urinary phenols by gut bacteria and their possible role in the causation of large bowel cancer. Am J Clin Nutr 1976, 29:1448-1454.
7. Liebich H.M., Buelow H.J., Kallmayer R. Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr 1982, 239:343-349.
8. Wahl H.G., Hoffmann A., Luft D., Liebich H.M. Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A 1999, 847:117-125.
9. Schatowitz B., Gercken G. Simultaneous determination of C2-C22 non-esterified fatty-acids and other metabolically relevant carboxylic-acids in biological-material by gas-chromatography of their benzyl-esters. J Chromatogr-Biomed 1988, 425:257-268.
10. Mitchell S.C., Zhang A.Q. Methylamine in human urine. Clin Chim Acta 2001, 312:107-114.
11. Zhang A.Q., Mitchell S.C., Smith R.L. Dimethylamine in human urine. Clin Chim Acta 1995, 233:81-88.
12. Zhang A.Q., Mitchell S.C., Ayesh R., Smith R.L. Determination of trimethylamine and related aliphatic amines in human urine by head-space gas chromatography. J Chromatogr 1992, 584:141-145.
13. Hradecky P. Volatile fatty-acids in urine and vaginal secretions of cows during reproductive-cycle. J Chem Ecol 1986, 12:187-196.
14. Rhodes G., Holland M.L., Wiesler D., Novotny M., Moore S.A., Peterson R.G., et al. Excretion of urinary volatile metabolites in response to alloxan induced diabetes of short duration in rats. J Chromatogr 1982, 228:33-42.
15. Liebich H.M., Al-Babbili O., Zlatkis A., Kim K. Gas-chromatographic and mass-spectrometric detection of low-molecular-weight aliphatic alcohols in urine of normal individuals and patients with diabetes mellitus. Clin Chem 1975, 21:1294-1296.
16. Quraishi M.N., Harrison L., Wedlake L., Ouaret N., Maxim J., Nwokolo C., et al. Sniffing gastrointestinal diseases with an electronic e-nose-is this the future for diagnostics?. Eur J Internal Med 2011, 22(Suppl. 1):S78.
17. Podebrad F., Heil M., Reichert S., Mosandl A., Sewell A.C., Bohles H. 4,5-Dimethyl-3-hydroxy-2[5H]-furanone (sotolone) - the odour of maple syrup urine disease. J Inherit Metab Dis 1999, 22:107-114.
18. Schoen E.J., Baker J.C., Colby C.J., To T.T. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics 2002, 110:781-786.
19. Diskin A.M., Spanel P., Smith D. Increase of acetone and ammonia in urine headspace and breath during ovulation quantified using selected ion flow tube mass spectrometry. Physiol Meas 2003, 24:191-199.
20. Smith D., Ismail K.M., Diskin A.M., Chapman G., Magnay J.L., Spanel P., et al. Increase of acetone emitted by urine in relation to ovulation. Acta Obstet Gynecol Scand 2006, 85:1008-1011.
21. Mozuraitis R., Buda V., Kutra J., Borg-Karlson A.K. p- and m-Cresols emitted from estrous urine are reliable volatile chemical markers of ovulation in mares. Anim Reprod Sci 2012, 130:51-56.
22. Banday K.M., Pasikanti K.K., Chan E.C., Singla R., Rao K.V., Chauhan V.S., et al. Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal Chem 2011, 83:5526-5534.
23. Willis C.L., Cummings J.H., Neale G., Gibson G.R. Nutritional aspects of dissimilatory sulfate reduction in the human large intestine. Curr Microbiol 1997, 35:294-298.
24. Cornu J.N., Cancel-Tassin G., Ondet V., Girardet C., Cussenot O. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur Urol 2011, 59:197-201.
25. Spanel P., Smith D., Holland T.A., Al Singary W., Elder J.B. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 1999, 13:1354-1359.
26. Smith S., White P., Redding J., Ratcliffe N.M., Probert C.S.J. Application of similarity coefficients to predict disease using volatile organic compounds. Ieee Sens J 2010, 10:92-96.
27. Carrola J., Rocha C.M., Barros A.S., Gil A.M., Goodfellow B.J., Carreira I.M., et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res 2011, 10:221-230.
28. Silva C.L., Passos M., Camara J.S. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br J Cancer 2011, 105:1894-1904.
29. Matsumura K., Opiekun M., Oka H., Vachani A., Albelda S.M., Yamazaki K., et al. Urinary volatile compounds as biomarkers for lung cancer: a proof-of-principle study using odor signatures in mouse models of lung cancer. PLoS One 2010, 5:e8819.
30. Kim K., Aronov P., Zakharkin S.O., Anderson D., Perroud B., Thompson I.M., et al. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 2009, 8:558-570.
31. Osl M., Dreiseitl S., Pfeifer B., Weinberger K., Klocker H., Bartsch G., et al. A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry. Bioinformatics 2008, 24:2908-2914.
32. Jentzmik F., Stephan C., Miller K., Schrader M., Erbersdobler A., Kristiansen G., et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010, 58:12-18. discussion 20-1.
33. Hayward N.J. Headspace gas-liquid-chromatography for the rapid laboratory diagnosis of urinary-tract infections caused by enterobacteria. J Chromatogr 1983, 274:27-35.
34. Guernion N., Ratcliffe N.M., Spencer-Phillips P.T., Howe R.A. Identifying bacteria in human urine: current practice and the potential for rapid, near-patient diagnosis by sensing volatile organic compounds. Clin Chem Lab Med 2001, 39:893-906.
35. Turner A.P.F., Magan N. Electronic noses and disease diagnostics. Nat Rev Microbiol 2004, 2:161-166.
36. Persaud K.C., Pisanelli A.M., Evans P., Travers P.J. Monitoring urinary tract infections and bacterial vaginosis. Sensor Actuat B - Chem 2006, 116:116-120.
37. Schaechter M., Medoff G., Eisenstein B.I. Mechanisms of microbial disease 1992, Williams & Wilkins, Baltimore. 2nd ed.
38. Griebling T.L. Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 2005, 173:1281-1287.
39. Barnett B.J., Stephens D.S. Urinary tract infection: an overview. Am J Med Sci 1997, 314:245-249.
40. Hellstrom A., Hanson E., Hansson S., Hjalmas K., Jodal U. Association between urinary symptoms at 7years old and previous urinary tract infection. Arch Dis Child 1991, 66:232-234.
41. Pantell R.H., Newman T.B., Bernzweig J., Bergman D.A., Takayama J.I., Segal M., et al. Management and outcomes of care of fever in early infancy. Jama 2004, 291:1203-1212.
42. Millar L., DeBuque L., Leialoha C., Grandinetti A., Killeen J. Rapid enzymatic urine screening test to detect bacteriuria in pregnancy. Obstet Gynecol 2000, 95:601-604.
43. Lumbiganon P., Laopaiboon M., Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol 2010, 22:95-99.
44. Bloomfield P., Hodson E.M., Craig J.C. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev 2003, CD003772.
45. Williams G.J., Macaskill P., Chan S.F., Turner R.M., Hodson E., Craig J.C. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis 2010, 10:240-250.
46. Jones B.D., Mobley H.L. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun 1987, 55:2198-2203.
47. Aathithan S., Plant J.C., Chaudry A.N., French G.L. Diagnosis of bacteriuria by detection of volatile organic compounds in urine using an automated headspace analyzer with multiple conducting polymer sensors. J Clin Microbiol 2001, 39:2590-2593.
48. Coloe P.J. Head-space gas liquid chromatography for rapid detection of Escherichia coli and Proteus mirabilis in urine. J Clin Pathol 1978, 31:365-369.
49. Manja K.S., Rao K.M. Gas-chromatographic detection of urinary tract infections caused by Escherichia coli and Klebsiella sp. J Clin Microbiol 1983, 17:264-266.
50. Pavlou A., Turner A.P.F., Magan N. Recognition of anaerobic bacterial isolates in vitro using electronic nose technology. Lett Appl Microbiol 2002, 35:366-369.
51. Kodogiannis V., Wadge E. The use of gas-sensor arrays to diagnose urinary tract infections. Int J Neural Syst 2005, 15:363-376.
52. Kodogiannis V.S., Lygouras J.N., Tarczynski A., Chowdrey H.S. Artificial odor discrimination system using electronic nose and neural networks for the identification of urinary tract infection. IEEE Trans Inf Technol Biomed 2008, 12:707-713.
53. Weber C.M., Cauchi M., Patel M., Bessant C., Turner C., Britton L.E., et al. Evaluation of a gas sensor array and pattern recognition for the identification of bladder cancer from urine headspace. Analyst 2011, 136:359-364.
54. Bate J.P., Irving P.M., Barrett J.S., Gibson P.R. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol 2010, 22:318-326.
55. Ruge E. Beiträge zur Kenntnis der Darmgase. Sitzungsberichte der Kaiserlichen. Akademie der Wissenschaften 1862, 42:739-762.
56. Tomlin J., Lowis C., Read N.W. Investigation of normal flatus production in healthy volunteers. Gut 1991, 32:665-669.
57. Suarez F., Furne J., Springfield J., Levitt M. Insights into human colonic physiology obtained from the study of flatus composition. Am J Physiol 1997, 272:G1028-G1033.
58. Gibson G.R., Macfarlane G.T., Cummings J.H. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut 1993, 34:437-439.
59. Miller T.L., Wolin M.J. Methanogens in human and animal intestinal tracts. Syst Appl Microbiol 1986, 7:223-229.
60. Cummings J.H. Short chain fatty acids in the human colon. Gut 1981, 22:763-779.
61. Yokoyama M.T., Carlson J.R. Microbial metabolites of tryptophan in the intestinal tract with special reference to skatole. Am J Clin Nutr 1979, 32:173-178.
62. Gostner A., Blaut M., Schaffer V., Kozianowski G., Theis S., Klingeberg M., et al. Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 2006, 95:40-50.
63. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
64. Mortensen P.B., Clausen M.R. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 1996, 216:132-148.
65. Smith E.A., Macfarlane G.T. Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 1997, 3:327-337.
66. Pitcher M.C., Beatty E.R., Cummings J.H. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulfide in patients with ulcerative colitis. Gut 2000, 46:64-72.
67. Cummings J.H., Hill M.J., Bone E.S., Branch W.J., Jenkins D.J. The effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr 1979, 32:2094-2101.
68. De Preter V., Van Staeyen G., Esser D., Rutgeerts P., Verbeke K. Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis. J Chromatogr A 2009, 1216:1476-1483.
69. Dixon E., Clubb C., Pittman S., Ammann L., Rasheed Z., Kazmi N. Solid-phase microextraction and the human fecal VOC metabolome. PLoS One 2011, 6:e18471.
70. Lington A.W., Bevan C. Alcohols. Patty's industrial hygiene and toxicology 1994, 2585-2760. Wiley, New York. G.D. Clayton (Ed.).
71. Elgaali H., Hamilton-Kemp T.R., Newman M.C., Collins R.W., Yu K., Archbold D.D. Comparison of long-chain alcohols and other volatile compounds emitted from food-borne and related Gram positive and Gram negative bacteria. J Basic Microbiol 2002, 42:373-380.
72. Perez Locas C., Yaylayan V.A. Origin and mechanistic pathways of formation of the parent furan-a food toxicant. J Agric Food Chem 2004, 52:6830-6836.
73. Seitz H.K., Matsuzaki S., Yokoyama A., Homann N., Vakevainen S., Wang X.D. Alcohol and cancer. Alcohol Clin Exp Res 2001, 25:137S-143S.
74. Vakevainen S., Tillonen J., Agarwal D.P., Srivastava N., Salaspuro M. High salivary acetaldehyde after a moderate dose of alcohol in ALDH2-deficient subjects: strong evidence for the local carcinogenic action of acetaldehyde. Alcohol Clin Exp Res 2000, 24:873-877.
75. Homann N. Alcohol and upper gastrointestinal tract cancer: the role of local acetaldehyde production. Addict Biol 2001, 6:309-323.
76. Decombaz J., Arnaud M.J., Milon H., Moesch H., Philippossian G., Thelin A.L., et al. Energy metabolism of medium-chain triglycerides versus carbohydrates during exercise. Eur J Appl Physiol Occup Physiol 1983, 52:9-14.
77. Kjeldsen F., Christensen L.P., Edelenbos M. Quantitative analysis of aroma compounds in carrot (Daucus carota L) cultivars by capillary gas chromatography using large-volume injection technique. J Agric Food Chem 2001, 49:4342-4348.
78. Ott A., Germond J.E., Chaintreau A. Vicinal diketone formation in yogurt: (13)C precursors and effect of branched-chain amino acids. J Agric Food Chem 2000, 48:724-731.
79. Salerno-Kennedy R., Cashman K.D. Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview. Wien Klin Wochenschr 2005, 117:180-786.
80. Deneris E.S., Stein R.A., Mead J.F. Acid-catalyzed formation of isoprene from a mevalonate-derived product using a rat liver cytosolic fraction. J Biol Chem 1985, 260:1382-1385.
81. Kjeldsen F., Christensen L.P., Edelenbos M. Changes in volatile compounds of carrots (Daucus carota L) during refrigerated and frozen storage. J Agric Food Chem 2003, 51:5400-5407.
82. De Lacy Costello B.P.J., Evans P., Ewen R.J., Gunson H.E., Jones P.R.H., Ratcliffe N.M., et al. Gas chromatography-mass spectrometry analyses of volatile organic compounds from potato tubers inoculated with Phytophthora infestans or Fusarium coeruleum. Plant Pathol 2001, 50:489-496.
83. Johnson W., Expert C.I.R. Final report on the safety assessment of Ethoxyethanol and Ethoxyethanol Acetate. Int J Toxicol 2002, 21:9-62.
84. Alloway B.J., Ayres D.C. Chemical principles of environmental pollution 1997, Blackie Academic & Professional, London. 2nd ed.
85. Herren-Freund S.L., Pereira M.A. Carcinogenicity of by-products of disinfection in mouse and rat liver. Environ Health Perspect 1986, 69:59-65.
86. Weisiger R.A., Pinkus L.M., Jakoby W.B. Thiol S-methyltransferase-suggested role in detoxication of intestinal hydrogen-sulfide. Biochem Pharmacol 1980, 29:2885-2887.
87. Moore J.G., Jessop L.D., Osborne D.N. Gas-chromatographic and mass-spectrometric analysis of the odor of human feces. Gastroenterology 1987, 93:1321-1329.
88. Suarez F.L., Springfield J., Levitt M.D. Identification of gases responsible for the odour of human flatus and evaluation of a device purported to reduce this odour. Gut 1998, 43:100-104.
89. Lechner A., Colvin H.P., Ginzel C., Lirk P., Rieder J., Tilg H. Headspace screening of fluid obtained from the gut during colonoscopy and breath analysis by proton transfer reaction-mass spectrometry: a novel approach in the diagnosis of gastro-intestinal diseases. Int J Mass Spectrom 2005, 243:151-154.
90. Fowler D. Analysis of volatile marker compounds in body fluid samples from patients with gastrointestinal disease 2010, Cranfield University, Cranfield.
91. Ahmed I., Probert C.S., Smith S., Ratcliffe N., Greenwood R. Diagnostic potential of volatile organic compounds in inflammatory bowel disease. Gastroenterology 2010, 138:S763-S764.
92. Bodelier A., Pierik M.J., Dallinga J.W., Van Berkel J., Moonen E., Hameeteman W., et al. Analysis of volatile organic compounds in exhaled air as a non invasive biomarker for inflammatory bowel disease (IBD). Gastroenterology 2009, 136:A35.
93. May T., Mackie R.I., Fahey G.C., Cremin J.C., Garleb K.A. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol 1994, 29:916-922.
94. Garner C.E., Smith S., Bardhan P.K., Ratcliffe N.M., Probert C.S. A pilot study of faecal volatile organic compounds in faeces from cholera patients in Bangladesh to determine their utility in disease diagnosis. Trans R Soc Trop Med Hyg 2009, 103:1171-1173.
95. Zlatkis A., Bertsch W., Lichtenstein H.A., Tishbee A., Shunbo F., Liebich H.M., et al. Profile of volatile metabolites in urine by gas chromatography-mass spectrometry. Anal Chem 1973, 45:763-767.
96. Zlatkis A., Brazell R.S., Poole C.F. The role of organic volatile profiles in clinical diagnosis. Clin Chem 1981, 27:789-797.
97. Wahl H.G., Hoffmann A., Luft D., Liebich H.M. Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A 1999, 847:117-125.
98. Smith D., Spanel P., Holland T.A., Al Singari W., Elder J.B. Selected ion flow tube mass spectrometry of urine headspace. Rapid Commun Mass Sp 1999, 13:724-729.
99. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.